PhaseBio plans $43M stock sale
April 12, 2019 at 11:20 AM EDT
The proceeds will be used by the Malvern biopharmaceutical company to advance both its lead new drug candidates.
Breaking News Bar
Business News and Information
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
| ||||||
bottom clear
